| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -26,242 | -17,251 |
| Depreciation and amortization | 2,532 | 1,689 |
| Stock-based compensation | 13,765 | 8,809 |
| Amortization of deferred income | 882 | 585 |
| Loss from equity method investment | -2,079 | -1,595 |
| Net accretion of discounts on available-for-sale securities | 306 | 221 |
| Other, net | -390 | -378 |
| Accounts receivable, net | -4,128 | -1,855 |
| Prepaid expenses and other assets | 3,740 | 2,261 |
| Accounts payable | -77 | 319 |
| Accrued expenses and other liabilities | 1,666 | -277 |
| Deferred revenue | 10,250 | 6,325 |
| Net cash provided by operating activities | 3,563 | 375 |
| Purchases of property and equipment | 1,254 | 538 |
| Purchases of available-for-sale securities | 25,308 | 17,160 |
| Proceeds from maturities of available-for-sale securities and other | 25,515 | 18,282 |
| Net cash (used in) provided by investing activities | -1,047 | 584 |
| Principal payments under vendor financing arrangements | 882 | 558 |
| Proceeds from exercise of stock options | 1,523 | 1,452 |
| Proceeds from employee stock purchase plan | 535 | 535 |
| Other financing activities | 99 | 27 |
| Net cash provided by (used in) financing activities | 1,275 | 1,456 |
| Net increase in cash, cash equivalents and restricted cash | 3,791 | 2,415 |
| Cash and cash equivalents at beginning of period | 14,072 | - |
| Cash and cash equivalents at end of period | 17,863 | - |
Arteris, Inc. (AIP)
Arteris, Inc. (AIP)